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Abstract: Graphene is a single atom-thick material with exciting potential. It can be used 
in many fields, from electronics to biomedicine. However, little is known about its toxicity 
and biocompatibility. Herein, we report a study on the toxicity of graphene platelets (GPs) by 
examining the influence of GPs on the morphology, mortality, viability, membrane integrity, 
and type of cell death of U87 and U118 glioma cells. It was found that graphene is toxic to 
glioma cells, but it activated apoptosis only in the U118 cell line, without inducing necrosis, 
indicating the potential applicability of GP in anticancer therapy.
Keywords: toxicity, glioma, apoptosis
Introduction
Glioblastoma multiforme, which originates from astroglial cells, is the most common 
brain tumor and has the highest degree of malignancy.1 It is characterized by infiltrative 
growth, intensive migration, and fast spread in brain tissues.2 Infiltration occurs along 
nerve fibers, blood vessels, via mater, and somata. Complete surgical resection of 
the glioma is impeded by this type of tumor growth, which is the reason for tumor 
recurrence and the necessity for chemotherapy. There are new experimental strategies 
for the treatment of glioma, especially regarding the mechanisms related to programmed 
cell death,3,4 that are raising hopes in cancer treatment. However, even the best drugs 
have strong negative effects on healthy cells and are distributed within the organism 
in an uncontrolled way. Thus, researchers are searching for apoptotic agents capable 
of targeting and destroying tumor tissue without any translocation to other cells.
Recently, new biologically active substances such as nanoparticles have been found 
to be useful in anticancer therapy. Many studies have shown that nanomaterials may 
have a positive effect on health, including through use in cancer treatment;5–7 however, 
some are still not well understood. For instance, there is a general lack of information 
about the recently developed substance “graphene.”
Graphene is one of the carbon allotropes and is regarded as the thinnest material in 
the world.8 A unique property of a graphene sheet is the ratio of its thickness to the size 
of its surface, which distinguishes this material from all other known nanomaterials. 
Graphene flakes may be similar to or greater in size than cells. This limits their mobility 
within tissues as well as their consumption by phagocytic cells. Further, graphene has 
unique physicochemical properties. A key feature is that its electrons move at very 
high speed8 and have different biological impacts on various cell and tissue types. As 
the charge of graphene may interfere with cell membranes by adhesion and by bonding 
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with cell receptors, it may block the supply of nutrients, 
induce stress, and activate apoptotic mechanisms in cancer 
cells. In addition, graphene has two active parts – surfaces 
and edges – so its edges can attach to biological molecules 
and its surfaces can adhere to cells.
Recently, investigations have studied the effects of 
functionalized graphene materials on living organisms. It 
has been demonstrated that both surface chemistry and size 
play key roles in controlling the biodistribution, toxicity, 
and excretion of graphene and, therefore, different graphene 
materials may have different effects on the organism.9 
The majority of the studies have focused on graphene 
oxide,9 which is produced by chemical methods; however, 
to the authors’ knowledge, there have been no biological 
studies of graphene platelets (GPs), which are produced by 
physical methods – that is, by direct exfoliation of graphite, 
without the initial stage of oxidation. The reduced GPs are 
hydrophobic, while graphene oxide is well dispersed in 
water, forming stable hydrocolloids. Given that GPs have 
specific physicochemical properties that differ from those of 
other graphene materials, we predicted that GPs might have 
different cellular toxicity.
We achieved promising results in our previous studies 
of diamond hydrophobic nanoparticles in glioma therapy.6 
In the present research, we hypothesized that GPs also have 
a toxic influence on glioma cells. The properties of glioma 
cells may vary depending on the cell line. In our study, two 
different human cell lines were used: U87 and U118. These 
lines are characterized by different morphology, activity of 
genes involved in cell-cycle regulation, and susceptibility to 
programmed cell death.10 The objective of the present study 
was to evaluate the toxicity of GPs as well as the pro-apoptotic 
and necrotic activities of graphene on tumor cells.
Materials and methods
Preparation and characterization of GPs
Graphene powder (purity . 99.99%) was purchased from 
SkySpring Nanomaterials (Houston, TX, USA). The powder 
was dispersed in ultrapure water to prepare a 1.0 mg/mL 
solution. After 30 minutes of sonification, the solution 
was diluted to different concentrations with 1× Dulbecco’s 
modified Eagle’s culture medium (Sigma-Aldrich, St Louis, 
MO, USA) immediately prior to exposure to cells.
The shape and size of the graphene sheets were inspected 
using a JEM-1220 (JEOL, Tokyo, Japan) transmission 
electron microscope (TEM) at 80 KeV, with a Morada 
eleven-megapixel camera (Olympus Soft Imaging Solutions, 
Münster, Germany). Samples for the TEM were prepared 
by placing droplets of hydrocolloids on to Formvar-coated 
copper grids (Agar Scientific, Stansted, UK). Immediately 
after drying of the droplets in dry air, the grids were inserted 
into the TEM. The test was performed in triplicate.
The zeta potential in water was measured using a 
Zetasizer Nano ZS model ZEN3500 (Malvern Instruments, 
Malvern, UK).
Cell cultures and treatments
Human glioblastoma U87 and U118 cell lines were obtained 
from the American Type Culture Collection (Manassas, 
VA, USA) and maintained in Dulbecco’s modified Eagle’s 
culture medium supplemented with 10% fetal bovine serum 
(Sigma-Aldrich), 1% penicillin, and streptomycin (Sigma-
Aldrich) at 37°C in a humidified atmosphere of 5% CO
2
/95% 
air in a NuAire DH AutoFlow CO
2
 Air-Jacketed Incubator 
(Plymouth, MN, USA).
Cell morphology
U87 and U118 cells were plated in six-well plates (1 × 105 
cells per well) and incubated for 24 hours. Cells cultured 
in medium without the addition of GPs were used as the 
control. Graphene was introduced to the cells at increasing 
concentrations (5, 10, 20, 50, and 100 µg/mL). Cell 
morphology was recorded using an optical microscope at 
24 hours post-exposure.
Cell mortality
Cell mortality was evaluated by Trypan blue assay (Sigma-
Aldrich). U87 and U118 cells were plated in six-well plates 
(5 × 105 cells per well) and incubated for 24 hours. After this, 
the medium was removed and GPs were introduced to the 
cells at increasing concentrations in the culture medium. Cells 
cultured without GPs were used as a control. Another 24 hours 
later, the medium was removed and the cells were detached 
with 300 µL of a trypsin-ethylenediaminetetraacetic acid 
(EDTA) solution. This mixture was centrifuged at 1200 rpm 
for 3 minutes. Then, 700 µL of Trypan blue solution was 
added to each well and dispersed. After 5 minutes, the cells 
were counted using a hemocytometer. Dead cells were stained 
blue. Cell mortality was expressed as the percentage of the 
dead cells in proportion to the total cell number.
Cell viability
The cell viability was evaluated using a 2,3-Bis-(2-methoxy-
4-nitro-5-sulfophenyl)-2H-tetrazolium-5-carboxyanilide salt 
(XXT) based cell proliferation assay kit (Life Technologies, 
Taastrup, Denmark). U87 and U118 were plated in 96-well 
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plates (5 × 103 cells per well) and incubated for 24 hours. 
Then, the medium was removed and GPs were introduced 
to the cells. In the next step, 50 µL of XTT solution was 
added to each well and incubated for an additional 3 hours 
at 37°C. The optical density (OD) of each well was recorded 
at 450 nm on an enzyme-linked immunosorbent assay 
reader (Infinite M200, Tecan, Durham, NC, USA). Cell 
viability was expressed as the percentage (OD
test
 - OD
blank
)/
(OD
control
 - OD
blank
), where “OD
test
” is the optical density of 
cells exposed to GPs, “OD
control
” is the optical density of the 
control sample, and “OD
blank
” is the optical density of wells 
without glioma cells.
Membrane integrity
A lactic dehydrogenase (LDH) test (undertaken using an 
LDH-based in vitro toxicology assay kit, Sigma-Aldrich) 
was used to evaluate cell membrane integrity. U87 and 
U118 cells were plated in 96-well plates (5 × 103 cells 
per well) and incubated for 24 hours. After this time, the 
medium was removed and GPs were introduced to the cells. 
After incubation with GPs, half of the volume of the culture 
medium was removed. A total of 100 µL of the lactate 
dehydrogenase assay mixture was added to each well. The 
plate was covered and incubated for 20 minutes at room 
temperature. The OD was recorded as outlined and the LDH 
leakage was expressed as the percentage of OD. The resulting 
reduced nicotinamide adenine dinucleotide (NADH+) was 
utilized in the stoichiometric conversion of a tetrazolium 
dye. When cell-free aliquots of the medium from cultures 
given different treatments were assayed, the amount of LDH 
activity could be used as an indicator of relative cell viability 
as well as a function of membrane integrity. If the membrane 
is damaged, intracellular LDH molecules are released into 
the culture medium. Thus, the LDH level in the medium 
indicates cell membrane integrity.
Apoptosis assay
An apoptosis kit (Alexa Fluor® 488 Annexin V/Dead 
Cell Apoptosis Kit with Alexa Fluor 488 Annexin V and 
propidium iodide (PI) for flow cytometry, Life Technologies) 
was used to detect apoptotic and necrotic cells. The 
manufacturer’s kit manual was strictly followed. U87 and 
U118 glioma cells were plated in six-well plates (1 × 105 
cells per well) and incubated for 48 hours. After this 
time, the medium was removed and GPs were introduced 
to the cells at only one test concentration (100 µg/mL) 
in the culture medium and incubated for another 24 hours. 
The positive control was prepared by culturing control cells 
in medium with 200 mM H
2
O
2
 for 30 minutes. U87 and 
U118 cells were harvested and washed in cold phosphate-
buffered saline. Next, the cells were transferred to tubes, 
centrifuged and suspended in Annexin Binding Buffer, 
5 µL of Alexa Fluor 488 Annexin V, and 1 µL of 100 µg/mL 
PI working solution were added to each 100 µL of the cell 
suspension. Glioma cells were analyzed by flow cytometry, 
measuring the fluorescence emission at 530 nm and 575 nm 
(or equivalent) using excitation at 488 nm. The cells 
were considered positive on the basis of the fluorescence 
intensity of Annexin V-Alexa Fluor 488 or PI. Positivity 
to Annexin V-Alexa Fluor 488 indicates the release of the 
phospholipid phosphatidylserine, which occurs in the early 
stage of apoptosis. Positivity for PI indicates damage to 
the cell membrane, which occurs not only in the end stage 
of apoptosis but also in necrosis. Apoptotic cells were 
identified as Annexin V-Alexa Fluor 488+ and PI-, non-viable 
cells as Annexin V-Alexa Fluor 488+ and PI+, and viable cells 
as Annexin V-Alexa Fluor 488- and PI-.
Statistical analysis
Data were analyzed using multifactorial analysis of variance 
with Statgraphics® Plus 4.1 (StatPoint Technologies, 
Warrenton, VA, USA). The differences between groups were 
tested using Tukey’s multiple range tests. All mean values 
are presented with the standard deviation.
Results
Characterization of GPs
Figure 1 shows representative TEM images of GPs. Most 
of the graphene sheets were visible as a single layer or a 
few layers. Their shape was irregular but rounded rather 
A B
C D
500 nm
500 nm
200 nm
1 µm
Figure 1 Characterization of graphene platelet samples (A–D) by transmission 
electron microscopy.
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than sharp and the flakes were often observed individually 
but still as separate layers. Diameter of the particles ranged 
from 450 nm to 1.5 µm. The mean zeta potential for the GPs 
was -9.61.
Cell morphology
Both cells lines were characterized by a different morphology 
and growth rate (Figure 2). U87 cells grew faster and the 
cells were not only larger and less branched but also had 
longer protrusions than the U118 cells. The U118 cells 
were smaller, more compact, and had shorter protrusions 
than the U87 cells. In both cases, it was noticeable that 
GP agglomerates attached to the cell body but not to the 
protrusions. A low number of free agglomerates indicated 
a high affinity for the studied cells. There was a clear 
difference between the GP-treated cells and the control 
cells. The GP-treated cells were more oval, denser, and their 
protrusions were shorter in comparison with the control 
cells. In addition, the GPs affected the adhesion of the cells 
to the plate.
Cell mortality
The cell mortality was monitored by Trypan blue exclusion 
assay, in which the dead cells are stained in blue while the 
living are not stained. Mortality was significantly different 
between cell lines and GP concentrations. GPs had the highest 
toxicity at a concentration of 100 µg/mL, with mortality 
of 42% and 52% for U87 and U118 cells, respectively 
(Figure 3).
Cell viability
The XTT-based cell proliferation assay is based on the ability 
of metabolically active cells to reduce the tetrazolium salt XTT 
into the orange-colored compound formazan. The greater the 
number of active cells in the well, the higher the activity of 
mitochondrial enzymes and concentration of the dye. The 
increased concentration of GPs resulted in decreased vitality 
in both glioma cell types. The lowest vitality was observed 
at the GP concentration of 100 µg/mL, with 54% and 58% 
in U87 and U118 cells, respectively (Figure 4).
Membrane integrity
If the cell membrane is damaged, intracellular LDH molecules 
may be released into the culture medium. Thus, the LDH level 
outside the cells demonstrates the cell membrane integrity. 
GPs disrupted cell membrane functionality and integrity and 
there were significant differences between cell lines and GP 
concentrations (Figure 5). Increased GP concentration led 
to greater glioma membrane damage, which was higher in 
U87 than in U118 cells.
Apoptosis assay
Apoptosis assay provides a simple and effective method for 
detecting one of the earliest events in apoptosis – the exter-
nalization of phosphatidylserine (PS) in living cells. Soon 
after apoptosis is induced, PS is translocated from the inner 
leaflet of the plasma membrane to the outer leaflet. This assay 
uses Annexin V, which has a strong and specific affinity for 
PS, monitoring the PS translocation due to apoptosis. GPs 
induced apoptosis and necrosis in U87 and U118 glioma 
cells (Figure 6). The degree of apoptosis was higher in both 
glioma cell types (68% in U87 and 99% in U118) than in the 
control group (9.2% in U87 and 18% in U118). The degree 
of necrosis was 24% in U87 and 1.7% in the control group, 
while it was only 0.2% in U118 cells.
Discussion
In this study, we evaluated the influence of graphene flakes on 
the morphology, viability, and mortality of glioblastoma cells. 
Because the surface of graphene and its functionalization play 
a key role in the physicochemical characteristics and thereby 
in the biocompatibility of different graphene materials,11 the 
present results may only be representative for the particular 
particles used here. Visualization of the GPs showed that 
the thickness of flakes was characteristic of graphene; that 
100 µm100 µm
100 µm100 µm
A B
C D
Figure 2 Optical microscopy images of graphene platelet (GP)-treated and 
untreated U87 and U118 glioma cells. (A) U87 control; (B) U118 control; (C) GP-
treated U87; (D) GP-treated U118.
Note: Arrows point to GP agglomerates.
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is, extremely thin as one layer of carbon atoms. However, 
the area of flakes was between 450 nm and 1.5 µm, thus 
not at nanoscale. The large surface area of the flakes did not 
allow graphene to enter into glioma cells, so GPs were not 
observed inside the cells. Chang et al12 examined the toxicity 
of graphene oxide on the A549 cell line and, similarly, did not 
observe the entry of graphene into the cells. However, in our 
experiments, we noted there was a strong tendency for the 
graphene flakes to be localized close to the cells, indicating 
an affinity of graphene for the cells. The same tendency was 
observed in a study on the influence of graphene on bacterial 
cells.13 In the present study, microscopic images of glioma 
cells and GP self-organization show that the GPs were adhered 
to the cells and, moreover, the flakes were usually connected to 
the cell body, not to its protrusions. This observation indicates 
a direct interaction between the GPs and cells caused by their 
chemical or/and physical properties. Furthermore, it indicates 
that this effect might depend on the morphology of the cells, 
especially the number and the shape of protrusions.
Assessment of cell viability showed a toxic influence of GPs 
on glioma cells. Using a concentration of 100 µg/mL resulted 
in a survival rate of 54% in U87 cells and 60% in the U118 
line. A similar result could be observed in the mortality test, 
as the same concentration caused death in 42% of U87 cells 
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Figure 3 Effect of graphene platelets on the mortality of U87 (blue) and U118 (red) glioma cells. 
Notes: There were no significant differences (P = 0.793) between the cell lines. The columns with different letters (a–e) indicate significant differences between the 
concentrations (P = 0.001).
Abbreviation: C, control group (untreated cells).
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Figure 4 Effect of graphene platelets on the viability of U87 (blue) and U118 (red) glioma cells. 
Notes: There were no significant differences (P = 0.104) between the cell lines. The columns with different letters (a–d) indicate significant differences between the 
concentrations (P = 0.008).
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and 52% of U118 cells, which is in line with other reported 
results of researchers who have demonstrated the high toxic-
ity of graphene oxide.14,15 However, there are also indications 
that graphene oxide has a low toxicity. When administered at 
low concentrations to human-derived cell lines A549 and SH-
SY5Y, no obvious cytotoxicity effects were observed.12,16–18 
Nevertheless, it has to be kept in mind that cytotoxicity of GPs 
cannot be directly compared with toxicity of graphene oxide, 
because these materials have different physicochemical proper-
ties and consequently may act differently on living organisms. 
Also, the comparisons with different cell lines (A549 and 
SH-SY5Y) are inconclusive because their morphology and 
functionality are different from those of U87 and U118 cells.
Although the toxicity of GPs in the present experiment 
was similar in both U87 and U118 cell lines, the effect on 
the cell membrane was different. Significant differences 
were seen after analyzing the integrity of membranes in the 
two glioma cell lines treated with GPs, using the LDH test. 
Membrane integrity was disrupted to a greater extent in 
U87 cells than in U118 cells, even at a low GP concentra-
tion. This may be explained by the different morphology of 
the cell lines. The surface of U118 cells is more branched 
than that of U87 cells and, as such, the cell membrane 
is longer and the proportion of protrusions to the central 
body of the cells is higher. Moreover, visualization of the 
bio-interactions between GPs and the cells showed that the 
GPs had a higher affinity to the body of the cells than to the 
protrusions. This may explain the mechanism of toxicity, 
which might depend on the surface of the cell membrane. 
As U118 cells have more branches than U87 cells, they have 
less of their central body surface exposed, thus a smaller area 
of the total cell membrane would have been affected by the 
GPs. Furthermore, the localization of receptors and subcel-
lular organelles within the central body and protrusions was 
different between the cell lines, which may have modified 
the biological effects of the GPs; this was evaluated in the 
second part of the study.
To explain the morphology-dependent mechanism of 
GP toxicity in different glioma cell lines, we investigated 
cell death using apoptosis and necrosis assays. The cell 
lines used in our experiment are characterized not only by 
different morphology but also by different activity of the 
genes involved in cell-cycle regulation and programmed 
cell death. The U118 cell line, in comparison to the U87, 
shows reduced expression of many genes, such as p53, p27, 
Bcl2, PTEN, and PARP.10 Exposure to graphene induced 
the process of apoptosis in both glioma cell lines but with 
different results: 68% in U87 cells and 99% in U118 cells. 
The activation of apoptosis was also observed in a study on 
the influence of graphene and nanotubes on the U251 glioma 
cell line, which was treated photothermally.19 Moreover, in 
our study, the level of necrosis was also different – 24% in 
U87 cells and 0.2% in U118 cells. This may indicate that the 
response to stress caused by GPs is controlled by molecular 
mechanisms. Consequently, U118 cells with reduced expres-
sion of the anti-apoptotic gene Bcl2 and/or the suppressor 
gene PTEN allow for much more intense switching in the 
molecular mechanisms involving apoptosis. In contrast, 
U87 cells exhibit a strongly controlled process of apoptosis 
in addition to necrosis mechanisms.
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Figure 5 Effect of graphene platelets on the membrane integrity of U87 (blue) and U118 (red) glioma cells. 
Notes: There were significant differences between the cell lines (P = 0.022). The columns with different letters (a–d) indicate significant differences between the concentrations 
(P , 0.038).
Abbreviation: LDh, lactate dehydrogenase.
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It has been demonstrated that graphene oxide affects not 
only the development of inflammation but also the activation 
of apoptotic cell death pathways in the respiratory system. 
It causes severe lung damage and leads to an increased rate 
of mitochondrial respiration and the generation of reactive 
oxygen species in lung cells.20,21 Also, in murine RAW 
264.7 macrophages, graphene oxide induces cytotoxicity 
through the depletion of the mitochondrial membrane 
potential, increasing production of intracellular reactive 
oxygen species and triggering apoptosis.22 In the present study, 
graphene caused glioma cell mortality to the same degree 
in both U118 and U87 cell lines; however, damage to cell 
membranes was much greater in U87 cells, suggesting that 
GPs may influence mechanisms of cell death by interfering 
with the mitochondrial respiration system and oxidative 
stress.
Graphene may block the delivery of nutrients to cancer cells 
by adhering to cell membranes. GPs may also interact with 
cell membrane surface receptors and can block the transport 
of various substances into the cell, inducing cellular stress 
and apoptosis.23 The precise mechanism of apoptosis is still 
unknown. However, it is clear that because of a mutation of the 
gene p53 in U118 cells, this gene is not involved in apoptosis 
activation. Furthermore, it has been shown that there are no 
changes in the expression of p53 and its target proteins during 
apoptosis activation in both U118 and U87 cell lines.24 This 
indicates that apoptosis could occur in a manner independent 
of p53, which suggests that there must be another mechanism 
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Figure 6 Annexin V-Alexa Fluor® 488 and propidium iodide (PI) assay analysis. Scatter diagrams of cells exposed to 100 µL/mL of graphene platelets (GPs). (A) U87 control; 
(B) U118 control; (C) GP-treated U87; (D) GP-treated U118. Different concentrations between control and treated groups are due to unlabeled GP agglomerates. rate of 
apoptosis and necrosis in U87 (E) and in U118 (F) cells.
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involved. Zhu and Weiss25 have demonstrated that inactivation 
of mouse Hus1 protein in primary cultured cells leads to 
chromosomal instability during DNA replication, triggering 
apoptosis and impairing proliferation through p53-independent 
mechanisms. In the present case, it is possible that Hus1 protein 
was blocked, causing apoptosis without activation of p53.
The present results are preliminary and follow-up 
research to elucidate the molecular mechanisms involved 
in the interactions between GPs and cells is necessary. At 
this stage, the results indicate that the contact between GPs 
and U87 and U118 cell membranes may be the key cause 
of GP toxicity. Consequently, the morphology of different 
glioma cells, the molecular status of cell lines, and the GP 
concentration may act together to regulate the biological 
response of glioma cells to GPs.
Conclusion
The results demonstrate that cytotoxicity of GPs on glioma 
cells increases with increasing GP concentrations from 
10 to 100 µg/mL. However, GPs only activate apoptosis 
without inducing necrosis in the U118 cell line, indicating 
the potential applicability of GPs in cancer therapy.
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